Sala de Prensa

European Medicines Agency Recommends Approval of Hexyon/Hexacima 6-in-1 Pediatric Vaccine

European Medicines Agency Recommends Approval of Hexyon/Hexacima 6-in-1 Pediatric Vaccine

- Hexyon/Hexacima will be the only fully liquid, ready-to-use,
6-in-1 pediatric vaccine in Europe -

 

Lyon, France - February 22, 2013 - Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended market approval for Sanofi Pasteur’s 6-in-1 pediatric vaccine HexyonTM/HexacimaTM (DTaP-IPV-Hib-HepB vaccine).

HexyonTM/HexacimaTM is the only fully liquid, ready-to-use, 6-in-1 vaccine to protect infants against diphtheria, tetanus, pertussis (whooping cough), Hepatitis B, poliomyelitis and invasive infections caused by Haemophilus in...